Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

被引:106
作者
Abood, ME [1 ]
Rizvi, G [1 ]
Sallapudi, N [1 ]
McAllister, SD [1 ]
机构
[1] Calif Pacific Med Ctr, Forbes Norris MDA ALS Res Ctr, San Francisco, CA 94115 USA
关键词
excitotoxicity; in vitro; cannabinoid receptor; neuroprotection; spinal;
D O I
10.1016/S0304-3940(01)02065-1
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Significant advances are being made towards understanding the genetic basis for spinal neurodegenerative diseases, however, effective pharmacotherapy remains elusive. One of the primary theories underlying neuron vulnerability is susceptibility to excitotoxicity. We present for the first time evidence that the activation of the CB1 cannabinoid receptor effectively modulates kainate toxicity in primary neuronal cultures prepared from mouse spinal cord. Addition of Delta (9)-tetrahydrocannabinol to the culture medium attenuated the toxicity produced by kainate. The CB1 receptors were localized to spinal neurons and astrocytes. The neuroprotective effect was blocked with the CB1 receptor antagonist, SR141716A, indicating a receptor-mediated effect (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:197 / 201
页数:5
相关论文
共 30 条
[1]
Molecular neurobiology of the cannabinoid receptor [J].
Abood, Mary E. ;
Martin, Billy R. .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 39, 1996, 39 :197-221
[2]
Endocannabinoids control spasticity in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Makriyannis, A ;
Khanolkar, A ;
Layward, L ;
Fezza, F ;
Bisogno, T ;
Di Marzo, V .
FASEB JOURNAL, 2001, 15 (02) :300-302
[3]
Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Huffman, JW ;
Layward, L .
NATURE, 2000, 404 (6773) :84-87
[4]
Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease [J].
Brotchie, JM .
MOVEMENT DISORDERS, 1998, 13 (06) :871-876
[5]
Carriedo SG, 1996, J NEUROSCI, V16, P4069
[6]
GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[7]
The perceived effects of smoked cannabis on patients with multiple sclerosis [J].
Consroe, P ;
Musty, R ;
Rein, J ;
Tillery, W ;
Pertwee, R .
EUROPEAN NEUROLOGY, 1997, 38 (01) :44-48
[8]
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease [J].
Di Marzo, V ;
Hill, MP ;
Bisogno, T ;
Crossman, AR ;
Brotchie, JM .
FASEB JOURNAL, 2000, 14 (10) :1432-1438
[9]
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action [J].
Di Marzo, V ;
Melck, D ;
Bisogno, T ;
De Petrocellis, L .
TRENDS IN NEUROSCIENCES, 1998, 21 (12) :521-528
[10]
NEUROPROTECTIVE AND ANTIOXIDANT ACTIVITIES OF HU-211, A NOVEL NMDA RECEPTOR ANTAGONIST [J].
ESHHAR, N ;
STRIEM, S ;
KOHEN, R ;
TIROSH, O ;
BIEGON, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 283 (1-3) :19-29